Neuropsychiatric lupus: clinical and imaging aspects
- PMID: 17922669
Neuropsychiatric lupus: clinical and imaging aspects
Abstract
Neuropsychiatric lupus (NPSLE) manifestations are common in adults and children and are associated with an increase in both morbidity and mortality. Cognitive dysfunction, when standardly assessed using sensitive neurocognitive instruments, is the most common NPSLE manifestation. The pathogenic etiologies of NPSLE manifestations are likely to be multifactorial and may involve autoantibody production, microangiopathy, intrathecal production of proinflammatory cytokines and athersclerosis. It is becoming more clear that the integrity of the blood-brain-barrier is very important in SLE-related neuropathology. Brain imaging is an important tool that allows us to evaluate the living brain. Thus far, anatomic brain imaging has revealed abnormalities such as subcortical white matter lesions and cerebral atrophy, but these findings are non-specific. Methods that evaluate metabolic processes and other functional imaging techniques have more promise as surrogates for central nervous system damage. This article reviews the current literature on clinical and imaging aspects of NPSLE.
Similar articles
-
Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.Scand J Rheumatol. 2005 Sep-Oct;34(5):376-82. doi: 10.1080/03009740510026643. Scand J Rheumatol. 2005. PMID: 16234185
-
Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.Arthritis Rheum. 2008 May;58(5):1451-7. doi: 10.1002/art.23452. Arthritis Rheum. 2008. PMID: 18438847
-
White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.Cogn Behav Neurol. 2009 Mar;22(1):38-44. doi: 10.1097/WNN.0b013e318190d174. Cogn Behav Neurol. 2009. PMID: 19372769
-
[Neurocognitive Disorders Caused by Central Nervous System Lupus Erythematosus].Brain Nerve. 2016 Apr;68(4):365-73. doi: 10.11477/mf.1416200406. Brain Nerve. 2016. PMID: 27056854 Review. Japanese.
-
Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).Best Pract Res Clin Rheumatol. 2002 Apr;16(2):229-44. doi: 10.1053/berh.2001.0223. Best Pract Res Clin Rheumatol. 2002. PMID: 12041951 Review.
Cited by
-
Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients.J Immunol Res. 2015;2015:920718. doi: 10.1155/2015/920718. Epub 2015 May 18. J Immunol Res. 2015. PMID: 26090505 Free PMC article.
-
Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain.J Pharm Bioallied Sci. 2014 Jul;6(3):198-204. doi: 10.4103/0975-7406.135247. J Pharm Bioallied Sci. 2014. PMID: 25035640 Free PMC article.
-
Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.Front Psychiatry. 2018 Feb 1;9:8. doi: 10.3389/fpsyt.2018.00008. eCollection 2018. Front Psychiatry. 2018. PMID: 29449817 Free PMC article.
-
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.Nat Rev Neurol. 2014 Oct;10(10):579-96. doi: 10.1038/nrneurol.2014.148. Epub 2014 Sep 9. Nat Rev Neurol. 2014. PMID: 25201240 Review.
-
Prevalence and Prognosis of Cerebrovascular Accidents and its Subtypes Among Patients with Systemic Lupus Erythematosus in Isfahan, Iran: A Hospital Clinic-based Study.Int J Prev Med. 2014 Jan;5(1):123-6. Int J Prev Med. 2014. PMID: 24555002 Free PMC article.